Tsukuba, Japan

Akira Naya


 

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 33(Granted Patents)


Location History:

  • Tsukuba, JP (2000 - 2011)
  • Ibaraki, JP (2012)

Company Filing History:


Years Active: 2000-2012

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Akira Naya: Innovator in Pharmaceutical Chemistry

Introduction

Akira Naya is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various health conditions. With a total of 9 patents to his name, Naya's work has had a substantial impact on medical research and drug development.

Latest Patents

Among his latest patents, Naya has developed substituted [1,2,4]triazolo[4',3′:1,6]pyrido[2,3-b]pyrazines, which are classified as inhibitors of AKT and are useful for cancer treatment. Additionally, he has created heteroaryloxy nitrogenous saturated heterocyclic derivatives that exhibit histamine-H3 receptor antagonistic or inverse-agonistic activity. These compounds are promising for the remedy and prevention of obesity, diabetes, hormone secretion disorders, and sleep disorders.

Career Highlights

Naya has worked with notable companies in the pharmaceutical industry, including Banyu Pharmaceutical Co. Ltd and MSD K.K. His innovative research has led to advancements in drug formulations and therapeutic applications, showcasing his expertise in the field.

Collaborations

Throughout his career, Naya has collaborated with esteemed colleagues, including Norikazu Otake and Yuji Haga. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.

Conclusion

Akira Naya's contributions to pharmaceutical chemistry and his innovative patents highlight his role as a key inventor in the industry. His work continues to influence the development of treatments for various health conditions, making a lasting impact on medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…